Support for drug companies to put prices in consumer ads

In a letter of support for the Defense, Labor, Health and Human Services and Education Appropriations Act for 2019, or HR 6157, the America’s Health Insurance Plans supports the requirement for drug companies to put prices in consumer ads. If HR 6157 is passed, the amendment would provide funding to enable the HHS to require disclosure of drug pricing information in direct-to-consumer advertising for prescription drugs. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.